A new article published in Advances in Radiation Oncology, an open access journal of the American Society for Radiation Oncology, shows radiation oncology ranks near the bottom in female representation relative to other specialties. In this podcast authors: Malika Siker MD, Curtiland Deville Jr. MD, Emma B. Holliday MD, and Nancy J. Tarbell MD, share their insights about ASTRO's Committee on Health Equity, Diversity and Inclusion (CHEDI), trends in gender representation, barriers to...
Howard Sandler, MD, MS, FASTRO, FASCO, and Scott Morgan, MD, MSc, FRCPC, discuss moderate hypofractionation and how men with early-stage prostate cancer can benefit. Sandler and Morgan are co-chairs of the panel that authored Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.
Dr. Shearwood McClelland III presents highlights from the first in a series of articles focused on radiation therapy access in the United States. Dr. McClelland is joined by Advances Editor-in-Chief Robert Miller, who discusses how disparities in access affect radiation oncology as a practice.
Editor Suzanne Evans, MD, and Benjamin Smith, MD, discuss ASTRO's new guideline on whole breast radiation therapy. This new guideline recommends that women with certain breast cancers can safety opt for a shorter 3-week regimen of radiation therapy vs the longer regimen of 6 to 8 weeks.